Pfizer’s earnings are Tuesday. What to see.

Pfizer’s earnings are Tuesday.  What to see.

Pfizer is set to report earnings on Tuesday, a week and a half after an executive told investors the company was considering a list price for its Covid-19 vaccine of between $110 and $130 per adult dose, higher than analysts had expected. The surprise has prompted analysts to rethink their estimates for next year’s Covid-19 … Read more

Pfizer aims for Covid vaccine price of at least $110 per dosage

Pfizer aims for Covid vaccine price of at least $110 per  dosage

Pfizer Inc. gave some details about its plans to sell the Covid-19 vaccine it developed with BioNTech SE on the commercial market in the United States, saying it expects to price the shot at $110 to $130 per dose for adults. The drugmaker is still negotiating with health insurers but expects the discussions to lead … Read more

Pfizer’s new Omicron targeting booster produces strong immune response

Pfizer’s new Omicron targeting booster produces strong immune response

The redesigned Covid-19 booster from Pfizer Inc. and BioNTech SE generated a strong immune response against the Omicron substrains BA.4 and BA.5, the companies said. The data, which the companies reported in a press release Thursday, provides the first window into how the new images rolling out across the U.S. are faring. An early look … Read more

AstraZeneca eyes cancer, RSV drugs for growth as demand for Covid vaccine wanes

AstraZeneca eyes cancer, RSV drugs for growth as demand for Covid vaccine wanes

AstraZeneca PLC produced one of the world’s most widely used Covid-19 vaccines. As demand for the shot ebbs, the company is focusing on tackling breast cancer and another respiratory virus. Now the company is scaling back production of its vaccine while lining up sequels to some blockbusters that have helped drive the company’s growth in … Read more

Pfizer requests authorization for children’s Covid-19 Booster

Pfizer requests authorization for children’s Covid-19 Booster

Pfizer Inc. and BioNTech SE asked US health authorities to clear the use of its updated Covid-19 booster in children aged 5 to 11 years. The companies made the request Monday as reformulated shots for people 12 and older roll out across the country. Health officials are urging people to get shots to increase protection … Read more

General Mills, Meta Platforms, Moderna: Stocks that defined the week

General Mills, Meta Platforms, Moderna: Stocks that defined the week

General Mills Inc. GIS -1.99% Companies that sell and make what we eat are fighting for consumer loyalty as inflation sends prices higher. Sales rose for Cheerios maker General Mills as more people want to save money by eating at home, while profits fell by about 16% at the dining chain Darden Restaurants Inc. The … Read more

Moderna Covid-19 Booster shortage leads to fewer appointments at pharmacies

Moderna Covid-19 Booster shortage leads to fewer appointments at pharmacies

Some US pharmacies and other vaccine providers only offer the new Covid-19 booster shot from Pfizer Inc. and BioNTech SE, after a manufacturing quality issue at a contract manufacturer caused shortages at Moderna Inc.’s new booster shot. In recent days, federal officials have informed state officials that there is a limited supply of Moderna’s updated … Read more

Covid-19 Booster Shots targeting Omicron approved, likely to be offered soon

Covid-19 Booster Shots targeting Omicron approved, likely to be offered soon

US health officials approved the use of reengineered Covid-19 vaccines targeting the latest versions of Omicron in preparation for a fall booster campaign that could start within days. The action by the Food and Drug Administration on Wednesday allows people 12 and older to receive an extra shot of the vaccine from Pfizer Inc. and … Read more

The latest Covid boosters are set to roll out before human testing is complete

The latest Covid boosters are set to roll out before human testing is complete

The Food and Drug Administration is expected to approve new Covid-19 booster shots this week without a staple of its normal decision-making process: data from a study showing whether the shots were safe and worked in people. Instead, the agency plans to evaluate the shots using data from other sources such as research in mice, … Read more